Nephroprotective effect of cystathionine is due to its diverse action on the kidney and Ehrlich ascites tumor cells

Pharmacological Reports

Volumn 59, Issue 5, 2007, Pages 553-564

  Kwiecień, Inga ^a   Sokołowska, Maria ^a   Włodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cisplatinum; Cystathionine; Ehrlich ascites tumor; Glutathione; Kidney; Nephrotoxicity

Indexed keywords

CISPLATIN; CYSTATHIONINE; CYSTATHIONINE GAMMA LYASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; REACTIVE OXYGEN METABOLITE; SULFUR; THIOL; THIOSULFATE SULFURTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SELECTIVITY; EHRLICH ASCITES TUMOR CELL; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; KIDNEY CELL; MONOTHERAPY; MOUSE; NEPHROTOXICITY; NONHUMAN; RENAL PROTECTION; TREATMENT OUTCOME;

EID: 38049130259     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Aebi E, Lauterberg BH: Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol, 1992, 263, R348-352.
2. Ajith TA, Nivitha V, Usha S: Zingiber officinale Roscoe alone and in combination with alpha-tocopherol protect the kidney against cisplatin-induced acute renal failure. Food Chem Toxicol, 2007, 45, 921-927.
3. Aw TY, Wierzbicka G, Jones DP: Oral glutatione increases tisuse glutatione in vivo. Chem Biol Interact, 1991, 80, 89-97.
4. Behling EB, Sendao MC, Francescato HD, Antunes LM, Costa RS, Bianchi MP: Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep, 2006, 58, 526-532.
5. Bondy SC, Guo SX: Effect of ethanol treatment on induction of emulative oxidative stress. Eur J Pharmacol, 1994, 270, 349-355.
6. Cooper AJ, Pinto JT: Cysteme S-conjugate beta-lyases. Amino Acids, 2006, 30, 1-15.
7. Cooper AJ: Biochemistry of sulfur-containing amino acids. Annu Rev Biochem, 1983, 52, 187-222.
8. Del Bello B, Paolicchi A, Comporti M, Pompella A, Maellaro E: Hydrogen peroxide produced during gamma-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintenance of proliferation in U937 cells. FASEB J, 1999, 13, 69-79.
9. Dillioglugil MO, Maral Kir H, Gulkac MD, Ozon Kanli A, Ozdogan HK, Acar O, Dillioglugil O: Protective effects of increasing vitamin E and A doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol Int, 2005, 75, 340-344.
10. Everet SA: Antioxidant drug design: a comparison of thiol and prooxidant reaction mechanisms. In: Biothiols in Health and Disease. Ed. Parker L, Cadenes E, Ed. New York, 1995, 49-64.
11. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P, Ciriob MR: Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J, 1998, 12, 479-486.
12. Gill PS, Wilcox CS: NADPH oxidaries in the kidney. Antioxid Redox Signal, 2006, 8, 1597-1607.
13. Gonzales R, Ramay C, Borrego A, Hernandez F, Merino N, Zamora Z, Rojas E: Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats. Mediat Infkamm, 2005, 14, 139-143.
14. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem, 1974, 248, 7130-7139.
15. Hades PC, May L, Hayes JD, Harrison DJ: Glutathione S-transferases in human liver cancer. Gut, 1991, 32, 1546-1549.
16. Hah SS, Stivers KM, de Vere White RW, Henderson PT: Kinetics of carboplatin - DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry. Chem Res Toxicol, 2006,19, 622-626.
17. Hardwick DF, Applegarth DA, Cockraft DM, Ross PH, Calder JR: Pathogenesis of methionine-induced toxicity. Metabolism, 1970, 19, 381-391.
18. Hinchman CA, Ballatori N: glutathione-degrating capacities of liver and kidney in different species. Biochem Pharmacol, 1990, 40, 1131-1135.
19. Iciek M, Włodek L: Biosynthesis and biological properties of compounds containing highly reactiye, reduced sulfane sulfur. Pol J Pharmacol, 2001, 53, 215-225.
20. Ikari A, Nagatani Y, Tsukimoto M, Harada H, Miwa M, Takagi K: Sodium dependent glucose transporter reduces peroxynitrite and cell injury caused by cis-platin in renal tubular epithelial cells. Biochim Biophys Acta, 2005, 1717, 109-117.
21. Jones MM, Basinger MA, Holscher MA: Thioeter suppression of cisplatin nephrotoxicity in the rat. Anticancer Res, 1991, 11, 449-453.
22. Kawai Y, Nakao T, Kunimura N, Kohoda Y, Gemba M: Relationship of intracellular calcium and oxygen radicals to cis-platin-related cell injury. J Pharmacol Sci, 2006, 100, 65-72.
23. Klatt P, Lamas S: Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem, 2000, 267, 4928-4944.
24. Kwiecień I, Michalska M, Włodek L: The selective effect of cystathionine on doxorubicin hepatotoxicity in tumor bearing mice. Eur J Pharmacol, 2006, 550, 39-46.
25. Lash LH: Role of glutathione transport processes in kidney function. Toxicol Appl Pharmacol, 2005, 2004, 329-342.
26. Lowry O, Rosebrough NJ, Fair AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem, 1951, 193, 265-275.
27. Matsushima H, Yonemura K, Ohishi K, Hishida A: The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med, 1998, 131, 518-526.
28. Meister A: Metabolism and transport of glutathione and other γ-glutamyl compounds. In: Function of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects. Ed. Larsson A, Orrenius S, Holmgren A, Mannervik B, Raven Press, New York, 1983, 1-22.
29. Mora Lde O, Antunes LM, Francescato HD, Bianchi Mde L: The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res, 2003, 47, 517-522.
30. Moron MS, Depierre JW, Mannervik B: Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta, 1979, 67, 582-589.
31. Naganuma A, Imura N: Role of metallothionein in cancer chemotheraphy. Gan To Kagaku Ryoho (abstract), 1994, 21, 301-306.
32. Ogasawara Y, Ishii K, Togawa T, Tanabe S: Determination of bound sulfur in serum by dialysis/bigh-performance liquid chromatography. Anal Biochem, 1993, 215, 73-81.
33. Ogasawara Y, Isoda S, Tanabe S: Tissue and subcellular distribution of bound and acid labile sulftir and the enzymatic capacity of sulfide production in the rat. Biol Pharm Bull, 1994, 17, 1535-1542.
34. Orłowski M, Meister A: γ-glutamyl-p-nitroanilidine. A new convenient substrate for determination and study of L-and D-γ-glutamyltranspeptidase activities. Biochim Biophys Acta, 1963, 73, 679-681.
35. Persa C, Pierce A, Ma Z, Kabil O, Lou MF: The presence of a transsulfuration pathway in the lens: a new oxidative stress defense system. Exp Eye Res, 2004, 79, 875-886.
36. 2 production, Biochim Biophys Acts, 2003, 1621, 76-83.
37. Pompella A, Visvikis A, Paolichi A, De Tat V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol, 2003, 66, 1499-1503.
38. Saga Y, Hashimoto H, Yachiku S, Iwata T, Tokumitsu M: Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine-tumors. Int J Urot, 2004, 11, 407-415.
39. Soda K: A spectrophotometric microdetermination of ketoacids with 3-methyl-2-benzothiazolone hydrazone. Agric Biol Chem, 1967, 31, 1054-1060.
40. Sörbo BH: Rhodanese. In: Methods in Enzymology, Vol. II. Ed. Collowick SP, Kaplan NO, Academic Press, New York, 1955, 334-337.
41. Stark AA, Porat N, Volohonsky G, Komlosh A, Bluvshtein E, Tubi C, Steinberg P: The role of gamma-glutamyl transpeptidase in the biosynthesis of glutathione. Biofactors, 2001, 174, 139-149,
42. Toohey F: Sulfane sulfur in biological systems: a possible regulatory role. Biochem J, 1989, 264, 625-632.
43. 2+ in the oxidative stress induced dissipation of the mitochondrial membrane potential. J Biol, Chem, 1994, 269, 14546-14552.
44. Wada K, Kamisaki Y, Nakamoto K, Itoh T: Effect of cystathionine as a scavenger of superoxide generated from human leukocytes or derived from xanthine oxidase in vitro. Eur J Pharmacol, 1996, 296, 335-340.
45. White AC, Tannical VJ, Fanburg BL: Glutathione deficiency in human disease. J Nutr Biochem, 1994, 5, 218-226.
46. Włodek L, Wróbel M, Czubak J: Transamination and transsulfuration of L-cysteine in Ehrlich ascites tumor cells and mouse liver. Int J Biochem, 1993, 25, 107-112.
47. Włodek L: Causes of L-cysteine neurotoxicity. Acta Biol Crac, 2002, 44, 15-24.
48. Włodek PJ, Smoleński OB, Chwatko G, Iciek MB, Miłkowski A, Bald E, Włodek L: Disruption of thiol homeostasis in plasma of terminal renal failure patients. Clin Chim Acta, 2006, 366, 137-145.
49. Wood JL: Sulfane sulfur. Methods Enzymol, 1987, 143, 25-29.
50. Wróbel M, Włodek L: Effects of thiazolidine-4-(R)cuboxylates and other low molecular-wieght sulfur compounds on the activity of mercaptopyruvate sulfurtransferase, rhodanese and cystationase in Ehrlich ascites tumor cells and tumor-bearing mouse liver. Amino Acids, 1997, 12, 309-314.
51. Zhang L, Cooper AJ, Krasnikov BF, Xu H, Bubber P, Pinto JT, Gibson GE, Hanigan MH: Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the α-ketoglutar dehydrogenase complexes in LLC-PK1 cells. Biochemistry, 2006, 45, 8959-8971.
52. Zou CG, Banerjee R: Tumor necrosis factor-alpha-induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis. J Biol Chem, 2003, 278, 16802-16808.